Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?

1 September 2020 (19:10 - 19:25)

Organised by:

Video

Sign in to view the resources

About the speaker

Doctor Alok Khorana

6 More presentations in this session

Presentation thumbnail

Welcome and introduction.

Professor S. Konstantinides (Mainz, DE)

Presentation thumbnail

Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.

Professor S. Konstantinides (Mainz, DE)

Presentation thumbnail

Q&A.

Presentation thumbnail

Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.

Professor J. Weitz (Hamilton, CA)

Presentation thumbnail

Q&A.

Access the full session

Session thumbnail

Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios

The Event

ESC Congress 2020

1 September 2020 19:10 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources